AMRX peer analysis
Amneal (AMRX) against its competitors: price, today's move, 1-year return and market value side by side.
AMRX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | $27.72 | 2.93% | 12.41% | $1.18B |
| ANIP ANI Pharmaceuticals | $70.69 | -1.82% | -23.10% | $1.65B |
| BHC Bausch Health | $8.03 | -2.07% | 21.48% | $3.07B |
| CPIX Cumberland Pharmaceuticals | $4.69 | 7.82% | 46.11% | $70.27M |
| EBS Emergent BioSolutions | $6.81 | -5.68% | -46.96% | $349.17M |
| INDV Indivior | $36.32 | 2.69% | 24.68% | – |
| PRGO Perrigo | $15.79 | 0.03% | -23.52% | $2.19B |
| RDY Dr. Reddy's Laboratories | $14.13 | -0.25% | 5.09% | $11.80B |
| TEVA Teva | $40.60 | -3.54% | 102.70% | $49.09B |
| VTRS Viatris | $18.68 | -1.86% | 80.31% | – |
| AMRX Amneal | $20.43 | -5.04% | 104.25% | $7.49B |
- AMRX's peers: AMPH (Amphastar Pharmaceuticals), ANIP (ANI Pharmaceuticals), BHC (Bausch Health), CPIX (Cumberland Pharmaceuticals), EBS (Emergent BioSolutions), INDV (Indivior), PRGO (Perrigo), RDY (Dr. Reddy's Laboratories).
Updated 2026-11-03 00:48 UTC